Jansen Valerie Malyvanh — SEC Form 4 filings

SEC reporting owner CIK 1889716. 6 Form 4 filings on record with FilingPulse; latest filed 2026-08-11.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-02-20 to 2026-08-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Elevation Oncology, Inc. (ELEV)CHIEF MEDICAL OFFICER26
OnKure Therapeutics, Inc. (OKUR)Director44

Form 4 filings — Jansen Valerie Malyvanh

FiledFormIssuerReported transactionsSource
2026-08-114OnKure Therapeutics, Inc. (OKUR)Grant/award (A): 22,350 (derivative) @ $0EDGAR
2026-06-084OnKure Therapeutics, Inc. (OKUR)Grant/award (A): 7,650 (derivative) @ $0EDGAR
2025-05-304OnKure Therapeutics, Inc. (OKUR)Grant/award (A): 7,650 (derivative) @ $0EDGAR
2025-02-194Elevation Oncology, Inc. (ELEV)Option exercise (M): 17,500 · Tax withholding (F): 5,189 @ $0.67 · Grant/award (A): 275,000 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0EDGAR
2024-10-084OnKure Therapeutics, Inc. (OKUR)Grant/award (A): 15,300 (derivative) @ $0EDGAR
2024-02-204Elevation Oncology, Inc. (ELEV)Grant/award (A): 225,000 (derivative) @ $0 · Grant/award (A): 70,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1889716 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →